260 related articles for article (PubMed ID: 8600793)
1. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin.
Li J; Lee YS
Ann Acad Med Singap; 1996 Jul; 25(4):526-30. PubMed ID: 8893923
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
Connolly M; Narayan S; Oxley J; de Berker DA
Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
[TBL] [Abstract][Full Text] [Related]
4. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression.
Tsuji T
J Cutan Pathol; 1997 Aug; 24(7):409-15. PubMed ID: 9274958
[TBL] [Abstract][Full Text] [Related]
5. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
Cheville JC; Bromley C; Argenyi ZB
J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
[TBL] [Abstract][Full Text] [Related]
6. Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy ... soon?
LeBoit PE
Am J Dermatopathol; 1995 Aug; 17(4):319-20. PubMed ID: 8600791
[No Abstract] [Full Text] [Related]
7. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
[TBL] [Abstract][Full Text] [Related]
8. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
9. The role of p53, Ki-67 and laminin expression in the differential diagnosis of keratoacanthoma and well-differentiated SCC.
Turan G; Altun E; Aslan F; Kulahci O
Indian J Pathol Microbiol; 2019; 62(4):561-565. PubMed ID: 31611440
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
12. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
[TBL] [Abstract][Full Text] [Related]
14. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
Lee YS; Teh M
Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
[TBL] [Abstract][Full Text] [Related]
15. Quantitative image analysis of p53 protein accumulation in keratoacanthomas.
Borkowski A; Bennett WP; Jones RT; Borkowski P; Harris CC; Ferreira LR; Kao GF; Trump BF
Am J Dermatopathol; 1995 Aug; 17(4):335-8. PubMed ID: 8600795
[TBL] [Abstract][Full Text] [Related]
16. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
17. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
19. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]